Skip to content

Use of a new biomaterial in oral surgery procedure to reduce pain and improve healing

Comparative evaluation of the efficacy of a novel biomaterial in wound healing and postoperative pain management in alveoloplasty. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084935
Enrollment
28
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Novel Biomaterial: Novel Biomaterial is an intermeshing of chitosan acting as a scaffold impregnated with AgNP and 2% lidocaine that will serve the purpose of wound healing and antibact

Sponsors

Department of Oral and Maxillofacial Surgery Dr DY Patil Dental College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients requiring bilateral alveoloplasty procedure

Exclusion criteria

Exclusion criteria: 1. Patients with any systemic diseases 2. Patients with known psychological disorder 3. Patients with history of allergy to lignocaine.

Design outcomes

Primary

MeasureTime frame
1. Wound Healing 2. PainTimepoint: 1. Wound Healing -1 week 2. Pain - 1 week

Secondary

MeasureTime frame
1. Rescue medications requirementTimepoint: 1 week

Countries

India

Contacts

Public ContactManoj Bafna

DR D Y Patil Dental College And Hospital

kalyani.bhate@dpu.edu.in9822099311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026